Sanofi Pentacel Revised Action Date Is Nov. 2
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA extends the combination vaccine’s action date for the second time, this time requesting lab validation information relating to the pertussis component, but not directly related to Pentacel.